Access to anti-retroviral drugs, female in Denmark
Denmark: Access to anti-retroviral drugs, female was 91.0% in 2023. ▲ Rising
Access to anti-retroviral drugs, female in Denmark, 2000–2023
Source: UNAIDS estimates. Measured in %.
Analysis
In 2023, access to anti-retroviral drugs, female in Denmark stood at 91.0%. That is the highest value across all 24 years on record.
Compared with earlier readings it is up 3.4% on the previous year and up 28.2% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Denmark peaked at 91.0% in 2023 and was at its lowest, 44.0%, in 2000.
That places Denmark 25th out of 141 countries with data for 2023, putting it in the top quarter.
The long-run direction has been consistently rising across the 24 years of available data.
Access to anti-retroviral drugs, female in Denmark, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 44.0% | — |
| 2001 | 45.0% | +2.3% |
| 2002 | 46.0% | +2.2% |
| 2003 | 48.0% | +4.3% |
| 2004 | 50.0% | +4.2% |
| 2005 | 50.0% | +0.0% |
| 2006 | 53.0% | +6.0% |
| 2007 | 54.0% | +1.9% |
| 2008 | 58.0% | +7.4% |
| 2009 | 62.0% | +6.9% |
| 2010 | 66.0% | +6.5% |
| 2011 | 70.0% | +6.1% |
| 2012 | 74.0% | +5.7% |
| 2013 | 71.0% | -4.1% |
| 2014 | 82.0% | +15.5% |
| 2015 | 82.0% | +0.0% |
| 2016 | 82.0% | +0.0% |
| 2017 | 83.0% | +1.2% |
| 2018 | 84.0% | +1.2% |
| 2019 | 85.0% | +1.2% |
| 2020 | 86.0% | +1.2% |
| 2021 | 87.0% | +1.2% |
| 2022 | 88.0% | +1.1% |
| 2023 | 91.0% | +3.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 51.0% | 44.0% | 62.0% | 10 |
| 2010s | 77.9% | 66.0% | 85.0% | 10 |
| 2020s | 88.0% | 86.0% | 91.0% | 4 |
Countries ranked near Denmark
- 22 France 93.0% compare
- 22 Malawi 93.0% compare
- 22 Morocco 93.0% compare
- 25 Saudi Arabia 91.0% compare
- 27 Ethiopia 90.0% compare
- 27 Haiti 90.0% compare
- 27 Ireland 90.0% compare
- 27 Kenya 90.0% compare
- 27 Romania 90.0% compare
- 27 Switzerland 90.0% compare
- 27 Tanzania, United Republic of 90.0% compare
- 27 Thailand 90.0% compare
More gender data for Denmark
- Child population (UN estimates and projections) 936.54 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.1147 % change on previous year (2030)
- Population 5,145 (2030)
- Working-age population (UN estimates and projections) 5,145 (2030)
- Population (UN estimates and projections), annual growth rate 0.2008 % change on previous year (2030)
- Age population, age 00, female, interpolated 28,897 (2025)
- Age population, age 00, male, interpolated 30,488 (2025)
- Age population, age 01, female, interpolated 28,736 (2025)
- Age population, age 01, male, interpolated 30,324 (2025)
- Age population, age 02, female, interpolated 28,778 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Denmark?
- Access to anti-retroviral drugs, female in Denmark was 91.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Denmark?
- The highest recorded value was 91.0% in 2023.
- What is the lowest access to anti-retroviral drugs, female recorded in Denmark?
- The lowest recorded value was 44.0% in 2000.
- How does Denmark rank for access to anti-retroviral drugs, female?
- Denmark ranks 25th out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, female rising or falling in Denmark?
- Over the last ten years it is up 28.2%. The long-run trend across the full record is rising.
- Where does this Denmark data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.